These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8806349)

  • 1. Propafenone pharmacokinetics and pharmacodynamics in patients with sustained ventricular tachycardia.
    Gillis AM; Wyse DG; Mitchell LB; Duff HJ
    Am J Cardiol; 1996 Sep; 78(5):579-81. PubMed ID: 8806349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous and oral propafenone for treatment of tachycardia in infants and children: pharmacokinetics and clinical response.
    Ito S; Gow R; Verjee Z; Giesbrecht E; Dodo H; Freedom R; Tonn GR; Axelson JE; Zalzstein E; Rosenberg HC; Koren G
    J Clin Pharmacol; 1998 Jun; 38(6):496-501. PubMed ID: 9650538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic and hemodynamic effects of intravenous propafenone in patients with recurrent ventricular tachycardia.
    Shen EN; Sung RJ; Morady F; Schwartz AB; Scheinman MM; DiCarlo L; Shapiro W
    J Am Coll Cardiol; 1984 May; 3(5):1291-7. PubMed ID: 6707382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics and pharmacodynamics of class I antiarrhythmic agents after a single oral administration].
    Yokota M; Toyama J; Ukai M; Miyahara T; Koide M; Kato R; Yasui S; Sotobata I
    Jpn Circ J; 1992; 56 Suppl 5():1480-4. PubMed ID: 1291746
    [No Abstract]   [Full Text] [Related]  

  • 5. Electrophysiological effects, efficacy and safety of intravenous propafenone in termination of atrioventricular nodal reentrant tachycardia and atrioventricular reentrant tachycardia: a prospective non-randomized interventional study.
    Pintarić H; Manola S; Nossan JS; Pavlović N; Delić-Brkljacić D; Radeljić V
    Acta Clin Croat; 2010 Mar; 49(1):25-31. PubMed ID: 20635581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular Tachycardia Induced by Propafenone Intoxication in a Pediatric Patient.
    Rosa M; Pappacoda S; DʼAnna C; Di Mita O; Ponticiello E; Marzuillo P; Tipo V
    Pediatr Emerg Care; 2019 Sep; 35(9):e164-e168. PubMed ID: 29095381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brugada-like phenomenon, induced by intravenous propafenone, in a patient with idiopathic fascicular ventricular tachycardia.
    Pino R; Sciortino G; Polizzi G
    J Cardiovasc Med (Hagerstown); 2013 May; 14(5):380-3. PubMed ID: 20414118
    [No Abstract]   [Full Text] [Related]  

  • 8. [Life-threatening ventricular arrhythmia during simultaneous administration of propafenone and sotatol].
    Gilewski W; Bednarska D; Sinkiewicz W
    Kardiol Pol; 2009 Aug; 67(8):916-20; discussion 921. PubMed ID: 19784892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of CYP2D6 polymorphism on the antiarrhythmic efficacy of propafenone in patients with paroxysmal atrial fibrillation during 3 months propafenone prophylactic treatment.
    Jazwinska-Tarnawska E; Orzechowska-Juzwenko K; Niewinski P; Rzemislawska Z; Loboz-Grudzien K; Dmochowska-Perz M; Slawin J
    Int J Clin Pharmacol Ther; 2001 Jul; 39(7):288-92. PubMed ID: 11471772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The efficacy and safety of intravenous propafenone in the acute treatment of spontaneous sustained ventricular tachycardia].
    Mestre JL; Moro C; Madrid AH; Novo L; Marín-Huerta E
    Rev Esp Cardiol; 1994 Jul; 47(7):461-7. PubMed ID: 8090973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
    Malfatto G; Zaza A; Forster M; Sodowick B; Danilo P; Rosen MR
    J Pharmacol Exp Ther; 1988 Aug; 246(2):419-26. PubMed ID: 3404440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic and electrophysiologic effects of oral propafenone.
    Prystowsky EN; Heger JJ; Chilson DA; Miles WM; Hubbard J; Zipes DP
    Am J Cardiol; 1984 Nov; 54(9):26D-28D. PubMed ID: 6496366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme induction in the elderly: effect of rifampin on the pharmacokinetics and pharmacodynamics of propafenone.
    Dilger K; Hofmann U; Klotz U
    Clin Pharmacol Ther; 2000 May; 67(5):512-20. PubMed ID: 10824630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of intravenous ibutilide vs. propafenone for rapid termination of recent onset atrial fibrillation.
    Zhang N; Guo JH; Zhang HCh; Li XB; Zhang P; Xn Y
    Int J Clin Pract; 2005 Dec; 59(12):1395-400. PubMed ID: 16351670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monomorphic and propafenone-induced polymorphic ventricular tachycardia in Brugada syndrome: a case report.
    Karaca M; Dinckal MH
    Acta Cardiol; 2006 Aug; 61(4):481-4. PubMed ID: 16970061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electrophysiologic effect of intravenous propafenone in supraventricular tachycardia].
    Iturralde P; Nunura F; Romero L; Colín L; Rosado J; Galván O; de Micheli A; González Hermosillo JA; Casanova JM
    Arch Inst Cardiol Mex; 1991; 61(2):135-41. PubMed ID: 1854228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pH on the myocardial uptake and pharmacodynamics of propafenone in the isolated rabbit heart.
    Gillis AM; Kates RE
    J Cardiovasc Pharmacol; 1988; 12(5):526-34. PubMed ID: 2468051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic interaction between mexiletine and propafenone in human beings.
    Labbé L; O'Hara G; Lefebvre M; Lessard E; Gilbert M; Adedoyin A; Champagne J; Hamelin B; Turgeon J
    Clin Pharmacol Ther; 2000 Jul; 68(1):44-57. PubMed ID: 10945315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-adrenergic stimulation modulates the sodium current block by propafenone in rat ventricular myocardium.
    Maier SK; Kirstein M
    J Electrocardiol; 2002 Oct; 35(4):343-9. PubMed ID: 12395362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiologic effects and efficacy of intravenous propafenone in terminating atrioventricular reentrant tachycardia in children.
    Hessling G; Brockmeier K; Ruediger HJ; Ulmer HE
    Am J Cardiol; 2001 Mar; 87(6):802-4, A9. PubMed ID: 11249911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.